Dermatomyositis Completed Phase 2 Trials for Methylprednisolone (DB00959)

Also known as: Dermatomyositides / Dermatopolymyositis, unspecified

IndicationStatusPhase
DBCOND0002234 (Dermatomyositis)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00004357Absorption of Corticosteroids in Children With Juvenile DermatomyositisTreatment